Evidence map›Paper›PMID 20858501›Full record

ReviewJournal of molecular and cellular cardiology2011

Nix Nought Nothing: fairy tale or real deal.

Gerald W Dorn

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular and cellular cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gerald W DornCenter for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA. gdorn@dom.wustl.edu
Washington University in St. Louis · US

Funding

MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHYR01HL059888 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 1999 to 2016
$5.4M
G-Protein Receptor Kinases in Cardiac Stress AdaptationR01HL087871 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2007 to 2016
$4.1M
CTRIP: Genetic Testing to Individualize Management of Common Heart DiseasesRC2HL102222 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2009 to 2010
$1.9M
Calpains as Mediators of Cardiac Ischemic InjuryR01HL080008 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2006 to 2010
$1.9M
NHLBI NIH HHS R01 HL059888NHLBI NIH HHS R01 HL080008NHLBI NIH HHS R01 HL087871NHLBI NIH HHS RC2 HL102222
6 · The paper itself

Abstract

Nix was first described in the heart as the protein product of a differentially expressed mRNA detected by hybridization to a partial cDNA sequence tag on an RNA expression array. Over the subsequent 8 years Nix has become the prototypical transcriptionally-regulated cardiac myocyte "suicide" gene and has been used as a model to interrogate mechanisms of programmed cardiomyocyte death in hypertrophy and heart failure. Nix stimulates conventional apoptosis mediated via the intrinsic mitochondrial pathway, but emerging evidence indicates that Nix also controls programmed necrosis dependent upon sarcoplasmic reticular-mitochondrial tethering, calcium cross-talk, and the mitochondrial permeability transition. Recent studies have also described Nix labeling of senescent cardiomyocyte mitochondria for autophagic elimination, elucidated a physiological mitochondrial quality control Nix function; so-called "mitochondrial pruning". This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."

Indexed as

AnimalsApoptosisCardiomegalyGene ExpressionGene Expression RegulationHeart FailureHumansMembrane ProteinsMolecular Targeted TherapyMyocardiumProto-Oncogene ProteinsTumor Suppressor ProteinsBNIP3L protein, humanMembrane ProteinsProto-Oncogene ProteinsTumor Suppressor Proteins

Identifiers

PMID20858501
PMCPMC3036779
OpenAlexW2081685763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.